Lung Cancer News

Beamion's Zongertinib Receives FDA Accelerated Approval for HER2-Mutant NSCLC as LUNG-1 Study Results Published in NEJM

Non-small cell lung cancer (NSCLC) · 3 min

TRI-611 Receives FDA Fast Track Designation for ALK-Positive Non-Small Cell Lung Cancer as Competition Intensifies

2 min

EMA Backs Amgen's Tarlatamab as First-in-Class BiTE Therapy for Advanced Small Cell Lung Cancer

EMA · oncology · 3 min

EMA Recommends First Bispecific T-Cell Engager for Relapsed Small Cell Lung Cancer

EMA · oncology - small cell lung cancer · 3 min